Cargando…

Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy

Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hamperin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Biao-Qi, Zhao, Yi, Zhang, Yang, Pan, Yu-Jing, Xia, Hong-Ying, Kankala, Ranjith Kumar, Wang, Shi-Bin, Liu, Gang, Chen, Ai-Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382433/
https://www.ncbi.nlm.nih.gov/pubmed/36017071
http://dx.doi.org/10.1016/j.bioactmat.2022.07.023
_version_ 1784769280032636928
author Chen, Biao-Qi
Zhao, Yi
Zhang, Yang
Pan, Yu-Jing
Xia, Hong-Ying
Kankala, Ranjith Kumar
Wang, Shi-Bin
Liu, Gang
Chen, Ai-Zheng
author_facet Chen, Biao-Qi
Zhao, Yi
Zhang, Yang
Pan, Yu-Jing
Xia, Hong-Ying
Kankala, Ranjith Kumar
Wang, Shi-Bin
Liu, Gang
Chen, Ai-Zheng
author_sort Chen, Biao-Qi
collection PubMed
description Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hampering the performance of nanomedicines. To address these issues, several immune-regulating camouflaged nanocomposites have emerged as prevailing strategies due to their unique characteristics and specific functionalities. In this review, we emphasize the composition, performances, and mechanisms of various immune-regulating camouflaged nanoplatforms, including polymer-coated, cell membrane-camouflaged, and exosome-based nanoplatforms to evade the immune clearance of nanoplatforms or upregulate the immune function against the tumor. Further, we discuss the applications of these immune-regulating camouflaged nanoplatforms in directly boosting cancer immunotherapy and some immunogenic cell death-inducing immunotherapeutic modalities, such as chemotherapy, photothermal therapy, and reactive oxygen species-mediated immunotherapies, highlighting the current progress and recent advancements. Finally, we conclude the article with interesting perspectives, suggesting future tendencies of these innovative camouflaged constructs towards their translation pipeline.
format Online
Article
Text
id pubmed-9382433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-93824332022-08-24 Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy Chen, Biao-Qi Zhao, Yi Zhang, Yang Pan, Yu-Jing Xia, Hong-Ying Kankala, Ranjith Kumar Wang, Shi-Bin Liu, Gang Chen, Ai-Zheng Bioact Mater Review Article Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hampering the performance of nanomedicines. To address these issues, several immune-regulating camouflaged nanocomposites have emerged as prevailing strategies due to their unique characteristics and specific functionalities. In this review, we emphasize the composition, performances, and mechanisms of various immune-regulating camouflaged nanoplatforms, including polymer-coated, cell membrane-camouflaged, and exosome-based nanoplatforms to evade the immune clearance of nanoplatforms or upregulate the immune function against the tumor. Further, we discuss the applications of these immune-regulating camouflaged nanoplatforms in directly boosting cancer immunotherapy and some immunogenic cell death-inducing immunotherapeutic modalities, such as chemotherapy, photothermal therapy, and reactive oxygen species-mediated immunotherapies, highlighting the current progress and recent advancements. Finally, we conclude the article with interesting perspectives, suggesting future tendencies of these innovative camouflaged constructs towards their translation pipeline. KeAi Publishing 2022-08-10 /pmc/articles/PMC9382433/ /pubmed/36017071 http://dx.doi.org/10.1016/j.bioactmat.2022.07.023 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Chen, Biao-Qi
Zhao, Yi
Zhang, Yang
Pan, Yu-Jing
Xia, Hong-Ying
Kankala, Ranjith Kumar
Wang, Shi-Bin
Liu, Gang
Chen, Ai-Zheng
Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title_full Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title_fullStr Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title_full_unstemmed Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title_short Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
title_sort immune-regulating camouflaged nanoplatforms: a promising strategy to improve cancer nano-immunotherapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382433/
https://www.ncbi.nlm.nih.gov/pubmed/36017071
http://dx.doi.org/10.1016/j.bioactmat.2022.07.023
work_keys_str_mv AT chenbiaoqi immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT zhaoyi immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT zhangyang immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT panyujing immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT xiahongying immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT kankalaranjithkumar immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT wangshibin immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT liugang immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy
AT chenaizheng immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy